House Cuts Orphan Drug Credit in Half as Part of Tax Reform Bill

Drug Industry Daily
A A
The House of Representatives moved closer to passing the final version of the Republicans’ tax reform legislation Tuesday, a sweeping $1.5 trillion measure that reduces or eliminates many deductions and credits — including cutting the orphan drug research tax credit in half.

To View This Article:

Login

Subscribe To Drug Industry Daily